Zivo Bioscience Inc. (ZIVO)
| Market Cap | 36.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.20M |
| Shares Out | 9.42M |
| EPS (ttm) | -1.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,263 |
| Open | 3.90 |
| Previous Close | 3.94 |
| Day's Range | 3.80 - 4.01 |
| 52-Week Range | 2.37 - 7.90 |
| Beta | -0.06 |
| Analysts | Buy |
| Price Target | 9.18 (+136.6%) |
| Earnings Date | Aug 15, 2022 |
About ZIVO
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal h... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ZIVO stock is "Buy." The 12-month stock price forecast is 9.18, which is an increase of 136.60% from the latest price.
News
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...
Zivo Bioscience Joins Russell Microcap® Index
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product ...
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
KEEGO HARBOR, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (“ZIVO” or the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medici...
Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted ...
KEEGO HARBOR, Mich., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscience as Shares Rocket on No News
ZIVO Bioscience (ZIVO) stock is rocketing higher on Friday despite no news concerning the company in what appears to be a pump and dump. The post ZIVO Stock: 6 Things to Know About Biotech ZIVO Bioscien...
ZIVO Stock: 8 Things to Know About Biotech Play Zivo Bioscience as Shares Rocket 155%+
Zivo Bioscience (ZIVO) stock is rocketing higher on Monday with heavy trading despite a lack of news coming from the company today. The post ZIVO Stock: 8 Things to Know About Biotech Play Zivo Bioscien...
Zivo Bioscience, Inc. Issues Letter to Shareholders
KEEGO HARBOR, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
ZIVO Bioscience to Present at the Q3 Virtual Investor Summit
Keego Harbor, Michigan--(Newsfile Corp. - August 11, 2021) - ZIVO Bioscience (NASDAQ: ZIVO) today announced that Andrew Dahl will be attending the Q3 Virtual Investor Summit. Event Q3 Investor Summit D...
Zivo Bioscience, Inc. Announces Closing of Underwriters' Partial Exercise of Over-Allotment Option in Connection with...
KEEGO HARBOR, Mich., July 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nu...
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercializati...
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical prod...
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Sup...
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of nutritional/nutraceutical pr...
ZIVO Bioscience to Participate in Maxim Group's Inaugural Emerging Growth Virtual Conference
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and additive pro...
ZIVO Bioscience Successfully Confirms Poultry Growth Promotion and Feed Conversion Ratio Improvements in Typical Prod...
KEEGO HARBOR, MI / ACCESSWIRE / January 11, 2021 / ZIVO Bioscience, Inc. (OTCQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic/additive product candid...
Zivo Bioscience Names Keith R. Marchiando as Chief Financial Officer
KEEGO HARBOR, MI / ACCESSWIRE / January 7, 2021 / ZIVO Bioscience, Inc. (OTCMQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, food and feed additive...